FALASCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.971
EU - Europa 168
AS - Asia 135
SA - Sud America 2
Totale 2.276
Nazione #
US - Stati Uniti d'America 1.969
SG - Singapore 100
RU - Federazione Russa 28
CN - Cina 27
DE - Germania 27
IE - Irlanda 26
IT - Italia 23
UA - Ucraina 17
FR - Francia 13
CZ - Repubblica Ceca 8
FI - Finlandia 7
GB - Regno Unito 7
PL - Polonia 6
JP - Giappone 3
BE - Belgio 2
CA - Canada 2
DK - Danimarca 2
KR - Corea 2
BR - Brasile 1
CL - Cile 1
IN - India 1
LK - Sri Lanka 1
NL - Olanda 1
SE - Svezia 1
TW - Taiwan 1
Totale 2.276
Città #
Wilmington 609
Houston 506
Woodbridge 365
Singapore 96
Fairfield 76
Chandler 61
Ashburn 44
Ann Arbor 35
Cambridge 27
Seattle 25
Dublin 21
Santa Clara 21
Medford 17
Dearborn 13
Rome 13
Beijing 12
Jacksonville 11
Brno 8
Lawrence 8
New York 8
Munich 6
San Diego 6
Kraków 5
Kunming 5
Menlo Park 5
Moscow 5
Engelhard 4
Council Bluffs 3
Helsinki 3
Palo Alto 3
Brussels 2
Creede 2
Hefei 2
La Veta 2
Osaka 2
Saint Petersburg 2
St. George 2
Toronto 2
Atlanta 1
Chengdu 1
Chiswick 1
Colombo 1
Hounslow 1
Kaohsiung 1
Lappeenranta 1
Los Angeles 1
Melegnano 1
Mountain View 1
Nanjing 1
North Hollywood 1
Novokuznetsk 1
Osasco 1
Pisa 1
Pune 1
Shanghai 1
Shijiazhuang 1
University Park 1
Warsaw 1
Washington 1
Totale 2.058
Nome #
Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. 396
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells 392
Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication 382
TG2 regulates the heat-shock response by the post-translational modification of HSF1. 319
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 305
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. 269
null 60
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois 41
ZFP750 affects the cutaneous barrier through regulating lipid metabolism 32
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 27
null 27
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma 23
Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis 20
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection 18
Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for covid-19 therapy 6
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 4
Totale 2.321
Categoria #
all - tutte 5.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020389 0 0 0 0 0 69 56 55 69 46 48 46
2020/2021379 49 45 43 40 37 43 41 50 11 7 11 2
2021/202286 8 6 0 3 1 10 8 10 3 5 11 21
2022/2023139 10 18 1 19 20 21 13 9 15 0 3 10
2023/202496 13 5 5 3 10 15 0 1 10 12 2 20
2024/2025207 6 100 49 17 15 20 0 0 0 0 0 0
Totale 2.321